U.S. ATP Assays Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Luminometric ATP Assays, Enzymatic ATP Assays), By Application (Drug Discovery & Development, Clinical Diagnostics), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Application
                       1.2.3. End use
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in U.S.
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Type outlook
                       2.2.2. Application outlook
                       2.2.3. End use outlook
                   2.3. Competitive Insights
Chapter 3. U.S. ATP Assays market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Rising emphasis on cell-based research in drug development
                           3.2.1.2. Increased adoption in food and beverage industry for hygiene monitoring
                           3.2.1.3. Expansion of biomanufacturing and bioprocess monitoring
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Limited specificity in complex biological samples
                           3.2.2.2. Availability of alternative assay techniques
                   3.3. U.S. ATP Assays market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. U.S. ATP Assays market: Type Estimates & Trend Analysis
                   4.1. Type Market Share, 2024 & 2033
                   4.2. Segment Dashboard
                   4.3. U.S. ATP Assays market by Type Outlook
                   4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                       4.4.1. Luminometric ATP Assays
                           4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.2. Enzymatic ATP Assays
                           4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
                           4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.4. Cell-based ATP Assays
                           4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       4.4.5. Others
                           4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. ATP Assays market: Application Estimates & Trend Analysis
                   5.1. Application Market Share, 2024 & 2033
                   5.2. Segment Dashboard
                   5.3. U.S. ATP Assays market by Application Outlook
                   5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                       5.4.1. Drug Discovery and Development
                           5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       5.4.2. Clinical Diagnostics
                           5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       5.4.3. Environmental Testing
                           5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       5.4.4. Food Safety and Quality Testing
                           5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       5.4.5. Others
                           5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. U.S. ATP Assays market: End use Estimates & Trend Analysis
                   6.1. End use Market Share, 2024 & 2033
                   6.2. Segment Dashboard
                   6.3. U.S. ATP Assays market by End use Outlook
                   6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                       6.4.1. Pharmaceutical and Biotechnology Companies
                           6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.2. Academic and Research Institutes
                           6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                       6.4.3. Hospital and Diagnostics Laboratories
                           6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Vendor Landscape
                       7.3.1. List of key distributors and channel partners
                       7.3.2. Key customers
                       7.3.3. Key company market share analysis, 2024
                       7.3.4. Thermo Fisher Scientific
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.4.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Promega Corporation
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. PerkinElmer Inc.
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. Becton, Dickinson and Company (BD)
                           7.3.7.1. Company overview
                           7.3.7.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.7.4. Strategic initiatives
                       7.3.8. Lonza Group Ltd.
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. Danaher Corporation
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. Abcam plc
                           7.3.10.1. Company overview
                           7.3.10.2. Financial performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. Quest Diagnostics Incorporated
                           7.3.11.1. Company overview
                           7.3.11.2. Financial performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives
                       7.3.12. Biomerieux SA
                           7.3.12.1. Company overview
                           7.3.12.2. Financial performance
                           7.3.12.3. Product benchmarking
                           7.3.12.4. Strategic initiatives
                       7.3.13. 3M Company
                           7.3.13.1. Company overview
                           7.3.13.2. Financial performance
                           7.3.13.3. Product benchmarking
                           7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. ATP assays market, by type, 2021 - 2033 (USD Million)
Table 3 U.S. ATP assays market, by application, 2021 - 2033 (USD Million)
Table 4 U.S. ATP assays market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in U.S.
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. ATP Assays market: market outlook
Fig. 10 U.S. ATP Assays competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. ATP Assays market driver impact
Fig. 16 U.S. ATP Assays market restraint impact
Fig. 17 U.S. ATP Assays market strategic initiatives analysis
Fig. 18 U.S. ATP Assays market: Type movement analysis
Fig. 19 U.S. ATP Assays market: Type outlook and key takeaways
Fig. 20 Luminometric ATP Assays market estimates and forecast, 2021 - 2033
Fig. 21 Enzymatic ATP Assays market estimates and forecast, 2021 - 2033
Fig. 22 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2021 - 2033
Fig. 23 Cell-based ATP Assays market estimates and forecast, 2021 - 2033
Fig. 24 Others market estimates and forecast, 2021 - 2033
Fig. 25 U.S. ATP Assays market: Application movement Analysis
Fig. 26 U.S. ATP Assays market: Application outlook and key takeaways
Fig. 27 Drug Discovery and Development market estimates and forecasts, 2021 - 2033
Fig. 28 Clinical Diagnostics market estimates and forecasts, 2021 - 2033
Fig. 29 Environmental Testing market estimates and forecasts, 2021 - 2033
Fig. 30 Food Safety and Quality Testing market estimates and forecasts, 2021 - 2033
Fig. 31 Others market estimates and forecasts, 2021 - 2033
Fig. 32 U.S. ATP Assays market: End use movement analysis
Fig. 33 U.S. ATP Assays market: End use outlook and key takeaways
Fig. 34 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2021 - 2033
Fig. 35 Academic and Research Institutes market estimates and forecasts, 2021 - 2033
Fig. 36 Hospital and Diagnostics Laboratories market estimates and forecasts, 2021 - 2033
Fig. 37 U.S. ATP Assays market share and leading players
Fig. 38 U.S. market share and leading players
Fig. 39 U.S. market estimates and forecasts, 2021 - 2033
Fig. 40 Market share of key market players - U.S. ATP Assays market